CVE detail

CVE-2022-45611 — CVE-2022-45611

Published 2023-08-22 · Modified 2026-06-17 · Vendor fresenius-kabi · Product pharmahelp_firmware · Source nvd

CRITICAL

severity

CVSS-derived band

9.8

CVSS v3

0–10 scale

0.0094

EPSS probability

exploitation probability, 30d

58.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.